Cargando…

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies

The global COVID-19 pandemic has caused massive disruptions in every society around the world. To help fight COVID-19, new molecular tools specifically targeting critical components of the causative agent of COVID-19, SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. The SARS-CoV-2 nucleocaps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terry, James S., Anderson, Loran BR, Scherman, Michael S., McAlister, Carley E., Perera, Rushika, Schountz, Tony, Geiss, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480041/ https://www.ncbi.nlm.nih.gov/pubmed/32908982 http://dx.doi.org/10.1101/2020.09.03.280370

Ejemplares similares

Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021)

Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006)

Nicotine has no significant cytoprotective activity against SARS-CoV-2 infection
por: Zheng, Fang, et al.
Publicado: (2022)

Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
por: Dangi, Tanushree, et al.
Publicado: (2022)

Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
por: Hodge, Curtis D., et al.
Publicado: (2021)

Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
por: Hodge, Curtis D., et al.
Publicado: (2021)

Electrochemical Capillary Driven Immunoassay for Detection of SARS-CoV-2
por: Clark, Kaylee M., et al.
Publicado: (2022)

Development of nucleocapsid-specific monoclonal antibodies for SARS-CoV-2 and their ELISA diagnostics on an automatic microfluidic device
por: Yang, Jihyun, et al.
Publicado: (2023)

Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2
por: Neff, Charles P., et al.
Publicado: (2023)

Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
por: Lu, Ruei-Min, et al.
Publicado: (2021)

Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes
por: Lee, Jong-Hwan, et al.
Publicado: (2022)

A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis
por: Zhu, An-Kai, et al.
Publicado: (2022)

The 19th Rocky Mountain Virology Association Meeting
por: Rovnak, Joel, et al.
Publicado: (2020)

Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies
por: Tian, Yuanyuan, et al.
Publicado: (2022)

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
por: Yamaoka, Yutaro, et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips
por: Xie, Chengzuo, et al.
Publicado: (2021)

Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA
por: He, Qigai, et al.
Publicado: (2005)

The 20th Anniversary Meeting of the Rocky Mountain Virology Association
por: Rovnak, Joel, et al.
Publicado: (2020)

Characterization of a Panel of Cross-Reactive Hantavirus Nucleocapsid Protein-Specific Monoclonal Antibodies
por: Avižinienė, Aliona, et al.
Publicado: (2023)

Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein
por: Cate, David M., et al.
Publicado: (2021)

Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals
por: Pushpakumara, Pradeep D., et al.
Publicado: (2023)

Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies
por: Kim, Jinsoo, et al.
Publicado: (2022)

Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron
por: Zhou, Bing, et al.
Publicado: (2022)

Generation of Recombinant Schmallenberg Virus Nucleocapsid Protein in Yeast and Development of Virus-Specific Monoclonal Antibodies
por: Lazutka, Justas, et al.
Publicado: (2014)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation
por: Coelho, Fabiana Fioravante, et al.
Publicado: (2023)

Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses
por: Wen, Yingfen, et al.
Publicado: (2023)

Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV
por: Zhao, Aizhi, et al.
Publicado: (2007)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters
por: Fagre, Anna C., et al.
Publicado: (2020)

Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus
por: Khramtsov, Y. V., et al.
Publicado: (2022)

Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein
por: Shin, Gu-Choul, et al.
Publicado: (2006)

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
por: Bolotin, Shelly, et al.
Publicado: (2021)

Aptamer/antibody sandwich method for digital detection of SARS-CoV2 nucleocapsid protein
por: Ge, Chenchen, et al.
Publicado: (2022)

Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
por: Ye, Qiaozhen, et al.
Publicado: (2021)

Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
por: Ye, Qiaozhen, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies
por: Loesche, Michael, et al.
Publicado: (2022)

High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
por: Fujisawa, Mizuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ufh33o7bn7k0ocsqn51d77q0k7